Broeders, M.,
Moss, S.,
Nystrom, L.,
Njor, S.,
Jonsson, H.,
Paap, E.,
Massat, N.,
Duffy, S.,
... Paci, E.
(2012).The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies.Journal of medical screening,19 Suppl 1, 14-25.
Clarke, C. N.,
Cortina, C. S.,
Fayanju, O. M.,
Dossett, L. A.,
Johnston, F. M.,
& Wong, S. L.
(2021).Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care.Annals of surgical oncology,Jun 7 [epub ahead of print]
de Blok, C. J. M.,
Wiepjes, C. M.,
Nota, N. M.,
van Engelen, K.,
Adank, M. A.,
Dreijerink, K. M. A.,
Barbe, E.,
Konings, I.,
& den Heijer, M.
(2019).Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.BMJ,365, l1652.
Duffy, S. W.,
Tabár, L.,
Yen, A. M.,
Dean, P. B.,
Smith, R. A.,
Jonsson, H.,
Törnberg, S.,
Chen, S. L.,
... Chen, T. H.
(2020).Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women.Cancer,126(13), 2971-2979.
Gøtzsche, P. C.,
& Nielsen, M.
(2011).Screening for breast cancer with mammography.Cochrane database of systematic reviews,(1), CD001877.
Hofvind, S.,
Ursin, G.,
Tretli, S.,
Sebuødegård, S.,
& Møller, B.
(2013).Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program.Cancer,119(17), 3106-3112.
IARC
(2002).Breast cancer screeningLyon:IARC Press.
Independent U. K. Panel on Breast Cancer Screening
(2012).The benefits and harms of breast cancer screening: an independent review.Lancet,380(9855), 1778-1786.
Mulder, R. L.,
Hudson, M. M.,
Bhatia, S.,
Landier, W.,
Levitt, G.,
Constine, L. S.,
Wallace, W. H.,
van Leeuwen, F. E.,
... Oeffinger, K. C.
(2020).Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group.Journal of clinical oncology,38(35), 4194-4207.
Njor, S.,
Nystrom, L.,
Moss, S.,
Paci, E.,
Broeders, M.,
Segnan, N.,
& Lynge, E.
(2012).Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.Journal of medical screening,19 Suppl 1, 33-41.
Njor, S. H.,
Schwartz, W.,
Blichert-Toft, M.,
& Lynge, E.
(2015).Decline in breast cancer mortality: how much is attributable to screening?.Journal of medical screening,22(1), 20-7.
Nystrom, L.,
Andersson, I.,
Bjurstam, N.,
Frisell, J.,
Nordenskjold, B.,
& Rutqvist, L. E.
(2002).Long-term effects of mammography screening: updated overview of the Swedish randomised trials.Lancet,359(9310), 909-919.
Research Council of Norway
(2015).Research based evaluation of the Norwegian Breast Cancer Screening Program: final reportOslo:Research Council of Norway.Hentet fra https://www.regjeringen.no/contentassets/444d08daf15e48aca5321f2cefaac511/mammografirapport-til-web.pdf
Sebuødegård, S.,
Botteri, E.,
& Hofvind, S.
(2020).Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway.Journal of the National Cancer Institute,112(8), 839-846.
Tabar, L.,
Vitak, B.,
Chen, H. H.,
Yen, M. F.,
Duffy, S. W.,
& Smith, R. A.
(2001).Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.Cancer,91(9), 1724-1731.
Weedon-Fekjær, H.,
Romundstad, P. R.,
& Vatten, L. J.
(2014).Modern mammography screening and breast cancer mortality: population study.BMJ,348, g3701.
Yen, M. F.,
Tabar, L.,
Vitak, B.,
Smith, R. A.,
Chen, H. H.,
& Duffy, S. W.
(2003).Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.European journal of cancer,39(12), 1746-1754.